Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Not Confirmed
Not Confirmed
24-27 July, 2025
KY/TN Water Profession...KY/TN Water Professionals
Not Confirmed
Not Confirmed
27-30 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Industry Trade Show
Not Confirmed
24-27 July, 2025
KY/TN Water Profession...KY/TN Water Professionals
Industry Trade Show
Not Confirmed
27-30 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
10 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250710336635/en/Quince-Therapeutics-Appoints-Leading-Immunologist-Dr.-Hassan-Abolhassani-to-Scientific-Advisory-Board
25 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250625603299/en/Quince-Therapeutics-to-Participate-at-A-T-Societys-2025-A-T-Clinical-Research-Conference
18 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250618606970/en/Quince-Therapeutics-Announces-Closing-of-Up-to-%2422-Million-Private-Placement-of-Securities
12 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250612439712/en/Quince-Therapeutics-Announces-Pricing-of-Up-to-%2422-Million-Private-Placement-of-Securities
03 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250603212072/en/Quince-Therapeutics-Exceeds-75-Enrollment-in-Pivotal-Phase-3-NEAT-Clinical-Trial-in-Ataxia-Telangiectasia
13 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250513193779/en/Quince-Therapeutics-Provides-Business-Update-and-Reports-First-Quarter-2025-Financial-Results
ABOUT THIS PAGE